172 related articles for article (PubMed ID: 21293925)
1. Hydrocortisone enhances the function of the blood-nerve barrier through the up-regulation of claudin-5.
Kashiwamura Y; Sano Y; Abe M; Shimizu F; Haruki H; Maeda T; Kawai M; Kanda T
Neurochem Res; 2011 May; 36(5):849-55. PubMed ID: 21293925
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of human peripheral nerve microvascular endothelial cell lines: a new in vitro blood-nerve barrier (BNB) model.
Abe M; Sano Y; Maeda T; Shimizu F; Kashiwamura Y; Haruki H; Saito K; Tasaki A; Kawai M; Terasaki T; Kanda T
Cell Struct Funct; 2012; 37(2):89-100. PubMed ID: 22672995
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells constituting blood-nerve barrier have highly specialized characteristics as barrier-forming cells.
Sano Y; Shimizu F; Nakayama H; Abe M; Maeda T; Ohtsuki S; Terasaki T; Obinata M; Ueda M; Takahashi R; Kanda T
Cell Struct Funct; 2007; 32(2):139-47. PubMed ID: 18057801
[TBL] [Abstract][Full Text] [Related]
4. Pericyte-derived glial cell line-derived neurotrophic factor increase the expression of claudin-5 in the blood-brain barrier and the blood-nerve barrier.
Shimizu F; Sano Y; Saito K; Abe MA; Maeda T; Haruki H; Kanda T
Neurochem Res; 2012 Feb; 37(2):401-9. PubMed ID: 22002662
[TBL] [Abstract][Full Text] [Related]
5. [Peripheral neuropathy and blood-nerve barrier].
Kanda T
Rinsho Shinkeigaku; 2009 Nov; 49(11):959-62. PubMed ID: 20030260
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.
Förster C; Burek M; Romero IA; Weksler B; Couraud PO; Drenckhahn D
J Physiol; 2008 Apr; 586(7):1937-49. PubMed ID: 18258663
[TBL] [Abstract][Full Text] [Related]
7. Peripheral nerve pericytes originating from the blood-nerve barrier expresses tight junctional molecules and transporters as barrier-forming cells.
Shimizu F; Sano Y; Maeda T; Abe MA; Nakayama H; Takahashi R; Ueda M; Ohtsuki S; Terasaki T; Obinata M; Kanda T
J Cell Physiol; 2008 Nov; 217(2):388-99. PubMed ID: 18543246
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod promotes blood-nerve barrier properties in vitro.
Nishihara H; Maeda T; Sano Y; Ueno M; Okamoto N; Takeshita Y; Shimizu F; Koga M; Kanda T
Brain Behav; 2018 Apr; 8(4):e00924. PubMed ID: 29670818
[TBL] [Abstract][Full Text] [Related]
9. [Blood-nerve barrier: structure and function].
Kanda T
Brain Nerve; 2011 Jun; 63(6):557-69. PubMed ID: 21613659
[TBL] [Abstract][Full Text] [Related]
10. Advanced glycation end-products induce basement membrane hypertrophy in endoneurial microvessels and disrupt the blood-nerve barrier by stimulating the release of TGF-β and vascular endothelial growth factor (VEGF) by pericytes.
Shimizu F; Sano Y; Haruki H; Kanda T
Diabetologia; 2011 Jun; 54(6):1517-26. PubMed ID: 21409414
[TBL] [Abstract][Full Text] [Related]
11. Peripheral nerve pericytes modify the blood-nerve barrier function and tight junctional molecules through the secretion of various soluble factors.
Shimizu F; Sano Y; Abe MA; Maeda T; Ohtsuki S; Terasaki T; Kanda T
J Cell Physiol; 2011 Jan; 226(1):255-66. PubMed ID: 20665675
[TBL] [Abstract][Full Text] [Related]
12. Barrier function in the peripheral and central nervous system-a review.
Reinhold AK; Rittner HL
Pflugers Arch; 2017 Jan; 469(1):123-134. PubMed ID: 27957611
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the nerve barrier and the blood dorsal root ganglion barrier in health and disease.
Reinhold AK; Rittner HL
Exp Neurol; 2020 May; 327():113244. PubMed ID: 32057794
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids induce transactivation of tight junction genes occludin and claudin-5 in retinal endothelial cells via a novel cis-element.
Felinski EA; Cox AE; Phillips BE; Antonetti DA
Exp Eye Res; 2008 Jun; 86(6):867-78. PubMed ID: 18501346
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator and neuropathy open the blood-nerve barrier with upregulation of microRNA-155-5p in male rats.
Reinhold AK; Yang S; Chen JT; Hu L; Sauer RS; Krug SM; Mambretti EM; Fromm M; Brack A; Rittner HL
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1160-1169. PubMed ID: 30625382
[TBL] [Abstract][Full Text] [Related]
16. Severity and patterns of blood-nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes.
Shimizu F; Sawai S; Sano Y; Beppu M; Misawa S; Nishihara H; Koga M; Kuwabara S; Kanda T
PLoS One; 2014; 9(8):e104205. PubMed ID: 25105500
[TBL] [Abstract][Full Text] [Related]
17. Selective blood-nerve barrier leakiness with claudin-1 and vessel-associated macrophage loss in diabetic polyneuropathy.
Ben-Kraiem A; Sauer RS; Norwig C; Popp M; Bettenhausen AL; Atalla MS; Brack A; Blum R; Doppler K; Rittner HL
J Mol Med (Berl); 2021 Sep; 99(9):1237-1250. PubMed ID: 34018017
[TBL] [Abstract][Full Text] [Related]
18. The distribution and expression of claudin-5 and occludin at the rat blood-optic nerve barrier after borneol treatment.
Jin D; Wang F; Qu L; Li Z; Jin L; Liu P; Xu X; Cui H
Mol Biol Rep; 2011 Feb; 38(2):913-20. PubMed ID: 20473716
[TBL] [Abstract][Full Text] [Related]
19. Biology of the blood-nerve barrier and its alteration in immune mediated neuropathies.
Kanda T
J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):208-12. PubMed ID: 23243216
[TBL] [Abstract][Full Text] [Related]
20. HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells.
András IE; Pu H; Deli MA; Nath A; Hennig B; Toborek M
J Neurosci Res; 2003 Oct; 74(2):255-65. PubMed ID: 14515355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
